United Therapeutics (UTHR) Total Debt (2017 - 2025)
Historic Total Debt for United Therapeutics (UTHR) over the last 14 years, with Q1 2025 value amounting to $200.0 million.
- United Therapeutics' Total Debt fell 6666.67% to $200.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $200.0 million, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $300.0 million for FY2024, which is 5714.29% down from last year.
- United Therapeutics' Total Debt amounted to $200.0 million in Q1 2025, which was down 6666.67% from $300.0 million recorded in Q4 2024.
- United Therapeutics' 5-year Total Debt high stood at $800.0 million for Q1 2021, and its period low was $200.0 million during Q1 2025.
- In the last 5 years, United Therapeutics' Total Debt had a median value of $800.0 million in 2021 and averaged $676.5 million.
- Per our database at Business Quant, United Therapeutics' Total Debt changed by 0.0% in 2021 and then plummeted by 6666.67% in 2025.
- United Therapeutics' Total Debt (Quarter) stood at $800.0 million in 2021, then changed by 0.0% to $800.0 million in 2022, then fell by 12.5% to $700.0 million in 2023, then plummeted by 57.14% to $300.0 million in 2024, then crashed by 33.33% to $200.0 million in 2025.
- Its Total Debt stands at $200.0 million for Q1 2025, versus $300.0 million for Q4 2024 and $400.0 million for Q3 2024.